Alios BioPharma is a clinical stage biopharmaceutical company in South San Francisco, California that is developing novel antiviral therapies for the treatment of respiratory diseases. Founded in 2008, Alios’ virology discovery and development platform consists of a proprietary chemical library of nucleoside analogs as well as novel virology-based screening systems. Alios is developing a portfolio of potential therapeutics for viral infections including respiratory syncytial virus (RSV), influenza, rhinovirus, and coronavirus. Alios’ lead compound, AL-8176, is a first-in-class, oral, anti-RSV nucleoside analog that is currently in Phase 2a studies for the treatment of RSV. AL-8176 is designed to inhibit the replication of RSV by acting on the viral polymerase. In vitro studies of the compound demonstrate potent and highly selective inhibition of both RSV laboratory-adapted A and B strains as well as a range of diverse clinical isolates. In addition, administration of AL-8176 resulted in potent multi-log suppression of RSV in an in vivo preclinical model. Phase 1 studies have been completed and there were no serious adverse events being reported and no adverse events leading to discontinuation. Alios has a number of preclinical programs targeting Influenza, Rhinovirus and RSV, diseases that infect millions of patients worldwide on an annual basis and cause significant morbidity and mortality.
View Top Employees from Alios BioPharmaWebsite | http://www.aliosbiopharma.com |
Revenue | $5 million |
Funding | $95.2 million |
Employees | 50 (19 on RocketReach) |
Founded | 2006 |
Address | 260 E Grand Ave, South San Francisco, California 94080, US |
Phone | (650) 635-5500 |
Fax | (650) 872-0584 |
Technologies |
JavaScript,
HTML,
PHP
+37 more
(view full list)
|
Industry | Biotechnology, Business Services General, Biopharma, Virology, Business Services, Health Care, Science and Engineering, Therapeutics |
Competitors | Abivax, Biokine Therapeutics Ltd., Cancer Prevention Pharmaceuticals, Inc, Eiger BioPharmaceuticals, Visterra Inc. |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Alios BioPharma employee's phone or email?
The Alios BioPharma annual revenue was $5 million in 2024.
19 people are employed at Alios BioPharma.
Alios BioPharma is based in South San Francisco, California.
The NAICS codes for Alios BioPharma are [32, 32541, 3254, 325].
The SIC codes for Alios BioPharma are [283, 28].